{
  "resourceType" : "Bundle",
  "id" : "cfsb1651596479133",
  "identifier" : {
    "system" : "https://www.gravitatehealth.eu/sid/doc",
    "value" : "EU/1/19/1370/002"
  },
  "type" : "document",
  "timestamp" : "2011-06-23T08:38:00+02:00",
  "entry" : [{
    "fullUrl" : "Composition/cfsb1651231019153",
    "resource" : {
      "resourceType" : "Composition",
      "id" : "cfsb1651231019153",
      "language" : "en",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Generated Narrative: Composition</b><a name=\"cfsb1651231019153\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;cfsb1651231019153&quot;  (Language &quot;en&quot;) </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155539)</span></p><p><b>date</b>: 2022-04-29 13:28:17+0000</p><p><b>author</b>: <a href=\"Organization-cfsb1665505132093.html\">Organization/cfsb1665505132093</a> &quot;Gilead Sciences Ireland UC&quot;</p><p><b>title</b>: TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets</p><h3>Attesters</h3><table class=\"grid\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-composition-attestation-mode.html\">CompositionAttestationMode</a>#official)</span></td><td>2002-08-01 13:28:17+0000</td></tr></table></div>"
      },
      "status" : "final",
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/",
          "code" : "100000155539"
        }],
        "text" : "Package Leaflet"
      },
      "subject" : [{
        "reference" : "RegulatedAuthorization/cfsb1665505019066"
      }],
      "date" : "2022-04-29T13:28:17Z",
      "author" : [{
        "reference" : "Organization/cfsb1665505132093"
      }],
      "title" : "TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets",
      "attester" : [{
        "mode" : {
          "coding" : [{
            "system" : "http://hl7.org/fhir/composition-attestation-mode",
            "code" : "official"
          }]
        },
        "time" : "2002-08-01T13:28:17Z"
      }],
      "section" : [{
        "title" : "B. Package Leaflet",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Package leaflet: Information for the patient Dovato 50 mg/300 mg film-coated tablets dolutegravir/lamivudine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.<ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div>"
        }
      },
      {
        "title" : "What is in this leaflet",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-0"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">What in this leaflet<ol><li>What Dovato is and what it is used for</li><li>What you need to know before you take Dovato</li><li>How to take Dovato</li><li>Possible side effects</li><li>How to store Dovato</li><li>Contents of the pack and other information</li></ol></div>"
        }
      },
      {
        "title" : "1. What Dovato is and what it is used for",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-1"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>1. What Dovato is and what it is used for</b> Dovato is a medicine that contains two active ingredients used to treat human immunodeficiency virus (HIV) infection: dolutegravir and lamivudine.</div>"
        }
      },
      {
        "title" : "2. What you need to know before you take Dovato",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-2"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>2. What you need to know before you take Dovato</b> Do not take Dovato<ul><li>if you are allergic (hypersensitive) to dolutegravir or lamivudine or any of the other ingredients of this medicine (listed in section 6).</li><li>If you are taking a medicine called fampridine (also known as dalfampridine; used in multiple sclerosis).</li></ul></div>"
        }
      },
      {
        "title" : "3. How to take Dovato",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-3"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>How to take Dovato</b><p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure</p><ul><li>The recommended dose of Dovato is <b>one tablet once a day.</b></li><li>If you are taking a medicine called fampridine (also known as dalfampridine; used in multiple sclerosis).</li></ul></div>"
        }
      },
      {
        "title" : "4. Possible side effects",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-4"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>4. Possible side effects</b></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them,<b>so it is very important to talk to your doctor about any changes in your health</b></p></div>"
        }
      },
      {
        "title" : "5. How to store Dovato",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-5"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>5. How to store Dovato</b><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.</p><p>This medicine does not require any special storage conditions.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p></div>"
        }
      },
      {
        "title" : "6. Contents of the pack and other information",
        "code" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/",
            "code" : "100000155538-6"
          }],
          "text" : "B. PACKAGE LEAFLET"
        },
        "text" : {
          "status" : "additional",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>6. Contents of the pack and other information</b> <b>What Dovato contains</b><ul><li>The active substances are dolutegravir and lamivudine. Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir and 300 mg lamivudine.</li><li>The other ingredients are microcrystalline cellulose, sodium starch glycolate, magnesium stearate, mannitol (E421), povidone (K29/32), sodium stearyl fumarate, hypromellose (E464), macrogol, titanium dioxide (E171).</li><li>This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodiumfree’.</li></ul></div>"
        }
      }]
    }
  },
  {
    "fullUrl" : "Organization/cfsb1665505181936",
    "resource" : {
      "resourceType" : "Organization",
      "id" : "cfsb1665505181936",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b><a name=\"cfsb1665505181936\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization &quot;cfsb1665505181936&quot; </p></div><p><b>identifier</b>: id: ORG-100013412 (use: OFFICIAL), id: LOC-100020264 (use: OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000032)</span></p><p><b>name</b>: European Medicines Agency</p><h3>Contacts</h3><table class=\"grid\"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)</td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://spor.ema.europa.eu/omswi",
        "value" : "ORG-100013412"
      },
      {
        "use" : "official",
        "system" : "https://spor.ema.europa.eu/omswi",
        "value" : "LOC-100020264"
      }],
      "active" : true,
      "type" : [{
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "/#220000000032"
        }],
        "text" : "Medicines Regulatory Authority"
      }],
      "name" : "European Medicines Agency",
      "contact" : [{
        "address" : {
          "use" : "work",
          "type" : "physical",
          "text" : "Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands",
          "line" : ["Carretera De Martorell 41 61, Poligono Industrial Nord-Est"],
          "city" : "Amsterdam",
          "postalCode" : "1083 HS",
          "country" : "nl"
        }
      }]
    }
  },
  {
    "fullUrl" : "Organization/cfsb1651149636159",
    "resource" : {
      "resourceType" : "Organization",
      "id" : "cfsb1651149636159",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b><a name=\"cfsb1651149636159\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization &quot;cfsb1651149636159&quot; </p></div><p><b>identifier</b>: id: ORG-100012958 (use: OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000034)</span></p><p><b>name</b>: ViiV Healthcare BV</p><h3>Contacts</h3><table class=\"grid\"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands(WORK)</td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://spor.ema.europa.eu/omswi",
        "value" : "ORG-100012958"
      }],
      "active" : true,
      "type" : [{
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "220000000034",
          "display" : "Marketing authorisation holder"
        }],
        "text" : "Marketing authorisation holder"
      }],
      "name" : "ViiV Healthcare BV",
      "contact" : [{
        "address" : {
          "use" : "work",
          "type" : "physical",
          "text" : "Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands",
          "line" : ["Van Asch van Wijckstraat 55H"],
          "city" : "Amersfoort",
          "country" : "NL"
        }
      }]
    }
  },
  {
    "fullUrl" : "RegulatedAuthorization/cfsb1665505019066",
    "resource" : {
      "resourceType" : "RegulatedAuthorization",
      "id" : "cfsb1665505019066",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"cfsb1665505019066\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization &quot;cfsb1665505019066&quot; </p></div><p><b>identifier</b>: id: EU/1/18/1289/001 (use: OFFICIAL)</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072062)</span></p><p><b>region</b>: European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#eu)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2018-06-21 13:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-cfsb1665505132093.html\">Organization/cfsb1665505132093</a> &quot;Gilead Sciences Ireland UC&quot;</p><p><b>regulator</b>: <a href=\"#Organization_cfsb1665505181936\">See above (Organization/cfsb1665505181936)</a></p></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "$spor-prod",
        "value" : "EU/1/18/1289/001"
      }],
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000072062"
        }],
        "text" : "Marketing Authorisation"
      },
      "region" : [{
        "coding" : [{
          "system" : "urn:iso:std:iso:3166",
          "code" : "eu"
        }],
        "text" : "European Union"
      }],
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active"
        }],
        "text" : "Active"
      },
      "statusDate" : "2018-06-21T13:28:17Z",
      "holder" : {
        "reference" : "Organization/cfsb1665505132093"
      },
      "regulator" : {
        "reference" : "Organization/cfsb1665505181936"
      }
    }
  },
  {
    "fullUrl" : "MedicinalProductDefinition/cfsb1665505991728",
    "resource" : {
      "resourceType" : "MedicinalProductDefinition",
      "id" : "cfsb1665505991728",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name=\"cfsb1665505991728\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicinalProductDefinition &quot;cfsb1665505991728&quot; </p></div><p><b>identifier</b>: id: 11102022</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-medicinal-product-type.html\">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-medicinal-product-domain.html\">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Biktarvy 50 mg/200 mg/25 mg film-coated tablets</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Biktarvy</p><p><b>type</b>: Invented name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: bictegravir/emtricitabine/tenofovir alafenamide</p><p><b>type</b>: Scientific name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 50 mg/200 mg/25 mg</p><p><b>type</b>: Strength part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: film-coated tablets</p><p><b>type</b>: Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000005)</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#eu)</span></td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#eu)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : [{
        "system" : "$spor-prod",
        "value" : "11102022"
      }],
      "type" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/medicinal-product-type",
          "code" : "MedicinalProduct",
          "display" : "Medicinal Product"
        }]
      },
      "domain" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/medicinal-product-domain",
          "code" : "Human"
        }],
        "text" : "Human use"
      },
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active",
          "display" : "Active"
        }]
      },
      "legalStatusOfSupply" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000072084"
        }],
        "text" : "Medicinal product subject to medical prescription"
      },
      "name" : [{
        "productName" : "Biktarvy 50 mg/200 mg/25 mg film-coated tablets",
        "type" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "220000000001",
            "display" : "Full name"
          }]
        },
        "part" : [{
          "part" : "Biktarvy",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "220000000002",
              "display" : "Invented name part"
            }]
          }
        },
        {
          "part" : "bictegravir/emtricitabine/tenofovir alafenamide",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "220000000003",
              "display" : "Scientific name part"
            }]
          }
        },
        {
          "part" : "50 mg/200 mg/25 mg",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "220000000004",
              "display" : "Strength part"
            }]
          }
        },
        {
          "part" : "film-coated tablets",
          "type" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "220000000005",
              "display" : "Pharmaceutical dose form part"
            }]
          }
        }],
        "usage" : [{
          "country" : {
            "coding" : [{
              "system" : "urn:iso:std:iso:3166",
              "code" : "eu",
              "display" : "European Union"
            }]
          },
          "jurisdiction" : {
            "coding" : [{
              "system" : "urn:iso:std:iso:3166",
              "code" : "eu",
              "display" : "European Union"
            }]
          },
          "language" : {
            "coding" : [{
              "system" : "urn:ietf:bcp:47",
              "code" : "en",
              "display" : "English"
            }]
          }
        }]
      }]
    }
  },
  {
    "fullUrl" : "PackagedProductDefinition/cfsb1667580052450",
    "resource" : {
      "resourceType" : "PackagedProductDefinition",
      "id" : "cfsb1667580052450",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"cfsb1667580052450\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PackagedProductDefinition &quot;cfsb1667580052450&quot; </p></div><p><b>identifier</b>: id: EU/1/18/1289/001 (use: OFFICIAL)</p><p><b>name</b>: Biktarvy 50 mg/200 mg/25 mg film-coated tablets</p><p><b>type</b>: Chemical Medicinal Prodcut <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2012-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 90 tablets</p><p><b>manufacturer</b>: <a href=\"Organization-cfsb1665505132093.html\">Organization/cfsb1665505132093</a> &quot;Gilead Sciences Ireland UC&quot;</p><h3>Packagings</h3><table class=\"grid\"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id: 654321</td><td>Child-resistant closure <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073504)</span></td><td>1</td><td>Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003529)</span></td></tr></table></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://spor.ema.europa.eu/pmswi",
        "value" : "EU/1/18/1289/001"
      }],
      "name" : "Biktarvy 50 mg/200 mg/25 mg film-coated tablets",
      "type" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "100000155527"
        }],
        "text" : "Chemical Medicinal Prodcut"
      },
      "packageFor" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "status" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/publication-status",
          "code" : "active",
          "display" : "Active"
        }]
      },
      "statusDate" : "2012-02-07T13:28:17Z",
      "containedItemQuantity" : [{
        "value" : 90,
        "unit" : "tablets"
      }],
      "manufacturer" : [{
        "reference" : "Organization/cfsb1665505132093"
      }],
      "packaging" : {
        "identifier" : [{
          "system" : "https://spor.ema.europa.eu/pmswi",
          "value" : "654321"
        }],
        "type" : {
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "100000073504",
            "display" : "Child-resistant closure"
          }]
        },
        "quantity" : 1,
        "material" : [{
          "coding" : [{
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "200000003529",
            "display" : "Cardboard"
          }]
        }]
      }
    }
  },
  {
    "fullUrl" : "AdministrableProductDefinition/cfsb1665507846505",
    "resource" : {
      "resourceType" : "AdministrableProductDefinition",
      "id" : "cfsb1665507846505",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: AdministrableProductDefinition</b><a name=\"cfsb1665507846505\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource AdministrableProductDefinition &quot;cfsb1665507846505&quot; </p></div><p><b>identifier</b>: id: 123456</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>administrableDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#10219000)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#15054000)</span></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#20053000)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000109093)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : [{
        "system" : "https://www.who-umc.org/phpid",
        "value" : "123456"
      }],
      "status" : "active",
      "formOf" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "administrableDoseForm" : {
        "coding" : [{
          "system" : "https://standardterms.edqm.eu/browse/get_concepts_by/SOM/SOM/",
          "code" : "10219000"
        }],
        "text" : "Tablet"
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "https://standardterms.edqm.eu/browse/get_concepts/UOP/",
          "code" : "15054000"
        }],
        "text" : "Tablet"
      },
      "routeOfAdministration" : [{
        "code" : {
          "coding" : [{
            "system" : "https://standardterms.edqm.eu/browse/get_concepts/ROA/",
            "code" : "20053000"
          }],
          "text" : "Oral use"
        },
        "targetSpecies" : [{
          "code" : {
            "coding" : [{
              "system" : "https://spor.ema.europa.eu/rmswi/",
              "code" : "/#100000109093"
            }],
            "text" : "Human"
          }
        }]
      }]
    }
  },
  {
    "fullUrl" : "ManufacturedItemDefinition/cfsb1667576615115",
    "resource" : {
      "resourceType" : "ManufacturedItemDefinition",
      "id" : "cfsb1667576615115",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name=\"cfsb1667576615115\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ManufacturedItemDefinition &quot;cfsb1667576615115&quot; </p></div><p><b>identifier</b>: id: EU/1/18/1289/001 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073665)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000002152)</span></p><p><b>manufacturer</b>: <a href=\"Organization-cfsb1665505132093.html\">Organization/cfsb1665505132093</a> &quot;Gilead Sciences Ireland UC&quot;</p></div>"
      },
      "identifier" : [{
        "use" : "official",
        "system" : "https://spor.ema.europa.eu/pmswi/#/",
        "value" : "EU/1/18/1289/001"
      }],
      "status" : "active",
      "manufacturedDoseForm" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "100000073665"
        }],
        "text" : "tablet"
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi",
          "code" : "200000002152"
        }],
        "text" : "Tablet"
      },
      "manufacturer" : [{
        "reference" : "Organization/cfsb1665505132093"
      }]
    }
  },
  {
    "fullUrl" : "Ingredient/cfsb1665505232916",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "cfsb1665505232916",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"cfsb1665505232916\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;cfsb1665505232916&quot; </p></div><p><b>identifier</b>: id: 4L5MP1Y7W7 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#00000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>BICTEGRAVIR SODIUM <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#4L5MP1Y7W7)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>50 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "4L5MP1Y7W7"
      },
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "00000072072"
        }],
        "text" : "active"
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "4L5MP1Y7W7",
              "display" : "BICTEGRAVIR SODIUM"
            }]
          }
        },
        "strength" : [{
          "presentationQuantity" : {
            "value" : 50,
            "unit" : "mg"
          },
          "basis" : {
            "coding" : [{
              "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
              "code" : "ACTIB"
            }],
            "text" : "active ingredient - basis of strength"
          }
        }]
      }
    }
  },
  {
    "fullUrl" : "Ingredient/cfsb1666195266647",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "cfsb1666195266647",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"cfsb1666195266647\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;cfsb1666195266647&quot; </p></div><p><b>identifier</b>: id: EL9943AG5J (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>tenofovir alafenamide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#EL9943AG5J)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>25 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "EL9943AG5J"
      },
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "100000072072",
          "display" : "active"
        }]
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "EL9943AG5J",
              "display" : "tenofovir alafenamide"
            }]
          }
        },
        "strength" : [{
          "presentationQuantity" : {
            "value" : 25,
            "unit" : "mg"
          },
          "basis" : {
            "coding" : [{
              "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
              "code" : "ACTIB"
            }],
            "text" : "active ingredient - basis of strength"
          }
        }]
      }
    }
  },
  {
    "fullUrl" : "Ingredient/cfsb1666197397224",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "cfsb1666197397224",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"cfsb1666197397224\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;cfsb1666197397224&quot; </p></div><p><b>identifier</b>: id: OP1R32D61U (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Microcrystalline cellulose <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#OP1R32D61U)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "OP1R32D61U"
      },
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "100000072082"
        }],
        "text" : "Excipient"
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "OP1R32D61U",
              "display" : "Microcrystalline cellulose"
            }]
          }
        }
      }
    }
  },
  {
    "fullUrl" : "Ingredient/cfsb1666197441225",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "cfsb1666197441225",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"cfsb1666197441225\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;cfsb1666197441225&quot; </p></div><p><b>identifier</b>: id: M28OL1HH48 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Croscarmellose sodium <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#M28OL1HH48)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "M28OL1HH48"
      },
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "100000072082"
        }],
        "text" : "Excipient"
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "M28OL1HH48",
              "display" : "Croscarmellose sodium"
            }]
          }
        }
      }
    }
  },
  {
    "fullUrl" : "Ingredient/cfsb1666197470356",
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "cfsb1666197470356",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b><a name=\"cfsb1666197470356\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;cfsb1666197470356&quot; </p></div><p><b>identifier</b>: id: 70097M6I30 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#MedicinalProductDefinition_cfsb1665505991728\">See above (MedicinalProductDefinition/cfsb1665505991728)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Magnesium stearate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#70097M6I30)</span></td></tr></table></blockquote></div>"
      },
      "identifier" : {
        "use" : "official",
        "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
        "value" : "70097M6I30"
      },
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/cfsb1665505991728"
      }],
      "role" : {
        "coding" : [{
          "system" : "https://spor.ema.europa.eu/rmswi/",
          "code" : "100000072082"
        }],
        "text" : "Excipient"
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "70097M6I30",
              "display" : "Magnesium stearate"
            }]
          }
        }
      }
    }
  }]
}